• TAVI/TAVR stands for Transcatheter Aortic Valve Implantation / Replacement.
• It treats a heart condition called aortic valve stenosis.
• Aortic valve stenosis causes narrowing or blockage of the valve that controls blood flow from the left ventricle to the aorta.
• TAVI/TAVR is a less invasive alternative to open-heart surgery.
• Instead of a large chest incision, a small incision is made in the groin or chest.
• A catheter is inserted through the blood vessels to reach the heart.
• A new artificial valve is placed inside the diseased aortic valve.
• The new valve is typically made of metal and tissue.
• It functions like a normal valve, allowing smooth blood flow.
• TAVI/TAVR replaces a damaged aortic valve without major surgery.
• It is used for older or high-risk patients who can't undergo open-heart surgery.
• TAVI/TAVR improves symptoms and heart function.
• It offers faster recovery, shorter hospital stays, and better quality of life for aortic valve stenosis patients.
• As with any medical procedure, there are potential risks and complications associated with TAVI/TAVR.
• These can include stroke, bleeding, infection, heart rhythm abnormalities, valve leakage, blood vessel damage, or allergic reactions.
• However, the overall risk profile is generally lower compared to traditional open-heart surgery.
• TAVI/TAVR has high success rates for aortic valve stenosis.
• Studies show improvements in symptoms, quality of life, and survival rates.
• Outcomes may vary based on patient factors and medical team experience.
• TAVI/TAVR provides long-term relief for aortic valve stenosis.
• Lifespan of the implanted valve varies.
• Durability depends on valve type, patient factors, and health conditions.
• Valve deterioration or malfunction may require further treatment or replacement.
• TAVI/TAVR has shorter recovery time than open-heart surgery.
• Hospital stay is usually a few days.
• Normal activities can be resumed within a few weeks.
• Recovery times vary based on health, age, and other conditions.
Balloon expandable valve 15 to 20 lakhs
Self-expanding second generation valve 19 to 24 lakhs
Self-expanding third generation valve 25 to 28 lakhs
Aortic valve replacement 5 lakhs approx.
Bioprosthetic valve 4 to 6 Lakhs.
TAVI/TAVR, or Transcatheter Aortic Valve Replacement, offers several significant benefits that make it a highly advantageous treatment option for individuals in need of aortic valve replacement. Some of the key benefits of TAVI/TAVR include:
1. Minimally Invasive: TAVI/TAVR is a minimally invasive procedure that does not require open-heart surgery. Instead, it involves accessing the heart through small incisions, typically in the groin or chest. This results in smaller scars, reduced pain, and faster recovery times compared to traditional open-heart surgeries.
2. Suitable for High-Risk Patients: TAVR is particularly beneficial for patients who are considered high-risk or inoperable for traditional surgical valve replacement. These individuals may have underlying health conditions, advanced age, or other factors that increase the risks associated with open-heart surgery. TAVR provides a safer alternative for these patients, allowing them to receive the necessary treatment without compromising their well-being.
3. Improved Quality of Life: TAVI/TAVR significantly improves the quality of life for patients with severe aortic valve stenosis. Prior to the procedure, individuals may experience symptoms such as shortness of breath, fatigue, and chest pain due to restricted blood flow. TAVI/TAVR effectively relieves these symptoms by replacing the diseased valve with a new functioning one, allowing for better circulation and improved heart function.
4. Reduced Hospital Stay: Compared to traditional surgical procedures, TAVI/TAVR typically requires a shorter hospital stay. Patients undergoing TAVI/TAVR often experience a faster recovery and can return to their daily activities sooner. This shorter hospitalization period reduces healthcare costs and allows individuals to resume their normal lives more quickly.
5. Lower Risk of Complications: TAVI/TAVR has been shown to have lower rates of complications compared to traditional surgeries. This is due to the less invasive nature of the procedure, reducing the likelihood of post-operative infections, bleeding, and other surgical risks. The lower complication rates contribute to better patient outcomes and improved safety profiles.
6. Long-Term Clinical Benefits: Research studies have demonstrated the long-term clinical benefits of TAVI/TAVR. Patients who undergo TAVI/TAVR experience improved survival rates, reduced hospital readmissions, and better overall cardiovascular health outcomes. TAVI/TAVR has proven to be a durable and effective treatment option for aortic valve stenosis, providing patients with long-lasting benefits.
Overall, TAVI/TAVR offers a less invasive, safer, and highly effective treatment option for individuals with aortic valve stenosis. Its numerous benefits, including faster recovery, improved quality of life, and lower risk of complications, make it an attractive choice for patients who are not suitable candidates for traditional open-heart surgery.
